ActX is one of the few laboratories to receive zero deficiencies on initial CAP inspection. Our team was very diligent in meeting CAP standards
SEATTLE (PRWEB) June 19, 2018
The Accreditation Committee of the College of American Pathologists (CAP) has awarded accreditation to ActX of Seattle, Washington based on results of a recent on-site inspection as part of the CAP’s Accreditation Programs.
The facility’s director, Charles Sailey, MD, was advised of this national recognition and congratulated for the excellence of the services being provided. ActX is one of more than 8,000 CAP-accredited facilities worldwide.
“ActX is one of the few laboratories to receive zero deficiencies on initial CAP inspection. Our team was very diligent in meeting CAP standards." said Charles Sailey, MD, Laboratory Director. “CAP is the largest laboratory quality assurance association in the world. The CAP Quality Assurance Program is the most respected and recognized laboratory accreditation program in the world and is often referred to as the Gold Standard.”
Andrew Ury, MD, CEO of ActX, said: “We are proud to have earned Laboratory accreditation from the College of American Pathologists. Our CAP policies ensure our laboratory is operating according to the highest standards, to the benefit of the patients and physicians that we serve."
The U.S. federal government recognizes the CAP Laboratory Accreditation Program, begun in the early 1960s, as being equal-to or more-stringent-than the government’s own inspection program.
During the CAP accreditation process, designed to ensure the highest standard of care for all laboratory patients, inspectors examine the laboratory’s records and quality control of procedures for the preceding two years. CAP inspectors also examine laboratory staff qualifications, equipment, facilities, safety program and record, and overall management.
About the College of American Pathologists
As the world’s largest organization of board-certified pathologists and leading provider of laboratory accreditation and proficiency testing programs, the College of American Pathologists (CAP) serves patients, pathologists, and the public by fostering and advocating excellence in the practice of pathology and laboratory medicine worldwide. For more information, read the CAP Annual Report at http://www.cap.org.
ActX helps physicians make better decisions about medical treatment, using patients’ genetic information. Integrated into the physician’s software tools and workflow, ActX analyzes the patient’s genetic information in real time and alerts physicians about drug-genome interactions, actionable hereditary risks and carrier status. For more information, visit http://www.actx.com, email email@example.com or call (888) 998-2289.